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A report on the Cold Spring Harbor Laboratory meeting
‘Eukaryotic mRNA Processing’, Cold Spring Harbor, USA, 20-
24 August 2003.
Amid the Cold Spring Harbor Laboratory celebrations
marking the 50thanniversary of the elucidation of the struc-
ture of DNA, researchers gathered to discuss recent
advances in understanding the mechanisms regulating gene
expression. The formation of a functional mRNA from the
initial pre-mRNA synthesized by RNA polymerase II
requires the addition of a cap and poly(A) tail as well as
removal of introns. These individual reactions have tradi-
tionally been studied in isolation, leading to a perception
that they are unconnected. It has, however, become clear
that the events that transform a pre-mRNA into an mRNA
are often carried out by large ribonucleoprotein (RNP) com-
plexes and that these reactions are coupled and interdepen-
dent. Interestingly, these events and the links between them
provide quality-control checkpoints to ensure that the
message encoded in the genome is accurately communicated
to the translation apparatus. These underlying concepts
framed the presentations we describe below.
Origins and mechanisms of pre-mRNA splicing 
The removal of introns from a pre-mRNA is catalyzed by a
large set of RNAs and proteins collectively termed the
spliceosome. Exciting advances have been made in the visu-
alization of the spliceosome complexes within the last year.
Cryoelectron micrographs presented by Melissa Jurica from
the laboratory of Melissa Moore (Brandeis University,
Waltham, USA), Cindy Will from Reinhard Lührmann’s
group (Max Planck Institute for Biophysical Chemistry, Göt-
tingen, Germany), and Melanie Ohi from the laboratory of
Thomas Walz (Harvard Medical School, Boston, USA) all
indicate that the active spliceosome (C complex) has three
domains of density surrounding a central cavity. The spliceo-
some structures are roughly 270 × 250 × 240 Å in size, with
resolutions  ranging between 20 Å and 40 Å. The current
challenges are to achieve greater resolution and to locate
important proteins and RNAs within the structure. We expect
that the generation of high-resolution structures of the
spliceosome will be as reinvigorating for research into the
biochemistry of splicing as the determination of the structure
of the ribosome has been for the study of translation.
Because the mechanism of pre-mRNA splicing by the
spliceosome is very similar to that observed for the group II
self-splicing introns, it has been widely postulated that the
catalytic core of the spliceosome would be formed by the
small nuclear RNAs (snRNAs). James Manley’s group at
Columbia University (New York, USA) previously reported
that a mixture of three RNA molecules derived from the
spliceosome and intron (U2 and U6 snRNAs and branch-
point RNA) has catalytic activity that produces an RNA
species called ‘RNA X’. This catalytic activity had only
limited similarity to splicing, however. At the conference,
Saba Valadkhan from the Manley laboratory reported that a
different product (RNA Y) is formed when the 5 splice site is
tethered to the U6 RNA. By several criteria, RNA Y resem-
bles the product of the first splicing step, in which the
branchpoint is linked to the 5 end of the intron through a
2-5 phosphodiester bond. It therefore appears that the
spliceosome is indeed a ribozyme.
Answers to the question of how introns arose during evolu-
tion have remained elusive. One long-standing hypothesis is
that introns arose very early and facilitated the evolution of
proteins by exon shuffling. Support for this hypothesis has
previously been found in the fact that introns are morefrequently found between codons than in the two positions
that interrupt codons. Richard Padgett (Cleveland Clinic
Foundation, USA) reported that this distribution is true only
for the major U2-dependent class of introns, and that a
minor class of U12-dependent introns is less frequently
found between codons. He suggested that these introns were
initially more prevalent, but have been unilaterally con-
verted to U2-type introns, and that the current distribution
of introns should not be used to address the introns-early
versus introns-late conundrum.
Interdependency of different processes  
Several presentations addressed the links between the RNA
processing events that lead to maturation of mRNA. One of
the most dramatic, by Susan Janicki from the laboratory of
David Spector (Cold Spring Harbor Laboratory, New York,
USA), included movies visualizing gene expression in living
mammalian cells. Using a reporter gene that allowed simul-
taneous localization of the gene, the RNA and the encoded
protein, as well as various tagged proteins, the group can
observe the different steps in gene expression. Upon activa-
tion of the gene, RNA polymerase II, splicing factors and
polyadenylation apparatus are all recruited to the site of
transcription and the encoded mRNA accumulates. Simulta-
neously, heterochromatin proteins leave the transgene locus
and the chromatin becomes less compact.
As splicing of pre-mRNA can occur co-transcriptionally, it is
possible that the rate of transcription could influence the
selection of 5 and/or 3 splice sites. Nicole Robson from the
group of Mariano Garcia-Blanco (Duke University, Durham,
USA) reported on experiments designed to test this hypothe-
sis in which they determined the effects of RNA pausing on
the alternative splicing of the pre-mRNA encoding the
fibroblast growth-factor receptor FGFR2. The team observed
that the regulation of alternative splicing of this pre-mRNA
required active transcription and that the presence of an
RNA polymerase II pause site promoted inclusion of nearby
exons. Similarly, Alberto Kornblihtt (University of Buenos
Aires, Argentina) described how his group used slow alleles
of RNA polymerase to demonstrate effects on multiple
modes of alternative splicing. Together, these studies indi-
cate an important role for RNA polymerase II in the control
of splicing.
Numerous studies have reported ‘unusual’ non-transcrip-
tional effects of promoter changes on gene expression. How
is it possible that promoter sequences can influence down-
stream events in gene expression? Emanuel Rosonina from
the laboratory of Benjamin Blencowe (University of
Toronto, Canada) described a correlation that the group
observed between the strength of activation and the effi-
ciency of splicing and 3-end cleavage, using a reporter gene
that can be activated by a variety of trans-acting factors.
From this observation, it was inferred that transcriptional
activators can influence recruitment of factors required for
pre-mRNA processing.
DNA damage leads to a strong but transient block in
polyadenylation. James Manley’s laboratory had previously
shown that a BRAC1/BARD1 heterodimer interacts with the
polyadenylation factor CstF and represses 3-end formation.
At this meeting, Frida Kleiman from the Manley lab reported
their further observations that the BRAC1/BARD1 factors
ubiquitinate the elongating, phosphorylated form of RNA
polymerase, RNAP IIO, and that this activity is dependent
on the presence of CstF. Collectively, their data suggest that
the targeted degradation of RNA polymerase during DNA
repair reflects functional interactions between the machiner-
ies for transcription, 3-end processing and DNA repair.
In yeast, where the number of introns is relatively low, DNA
microarrays have been generated that can distinguish each
unspliced pre-mRNA from its mature mRNA. Todd Burckin
from Grant Hartzog’s lab (University of California Santa
Cruz, USA) reported on a collaboration between the Hartzog
lab and Manuel Ares’ group (also at University of California
Santa Cruz) in which these ‘splicing-sensitive’ arrays were
used to understand better the effects of mRNA-processing
events on splicing by assaying the effects of 70 different
yeast mutants defective in mRNA synthesis and processing.
Their analysis revealed that defects in mRNA capping or
export affect the splicing of many genes. In contrast, muta-
tions in the carboxy-terminal domain of RNA polymerase II
affect only some genes, whereas mutants in the cleavage and
polyadenylation machinery have relatively little effect.
Maturation of the 3 ends of most pre-mRNAs requires a
site-specific cleavage followed by addition of the poly(A) tail.
The enzyme that synthesizes the tail, poly(A) polymerase,
was initially characterized and cloned in the early 1990s,
but the identity of the factor that mediates the cleavage
reaction has remained elusive. In a poster presentation
from Jim Manley’s lab, Kevin Ryan presented preliminary
data suggesting that the protein CPSF-73 (in metazoans, or
Ysh1p in yeast) is the long-sought endonuclease. This
protein is similar to members of the -CASP family, which
participate in nucleic acid metabolism. More significantly,
this factor is not present in the cytoplasmic polyadenylation
apparatus, which does not have a cleavage activity, and a
mutation in the predicted active site of Ysh1p is lethal.
Although it remains to be shown definitively that CPSF-73 has
endonuclease activity, this is a promising development in an
area that has frustrated researchers for a quarter of a century.
Alexandre Akoulitchev (University of Oxford, UK) reported
that termination of transcription of the human -globin
mRNA is dependent on cleavage of the nascent RNA. This
cleavage is distinct from the cleavage and polyadenylation
reaction and does not appear to require trans-acting factors.
Instead, cleavage occurs in cis by a ribozyme present in the
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served in the globin genes of primates, but it is unclear what
the function of this ribozyme is and whether similar
ribozymes are present in other genes.
Quality-control mechanisms in gene expression
and mRNA decay
One of the main factors that degrades aberrant mRNAs in
the nucleus is the exosome. David Tollervey (University of
Edinburgh, UK) reported the discovery of a new exosome
subunit, Rrp47p/Lrp1p. He also described gradient-centrifu-
gation and western-blotting experiments that show that the
Rrp6 protein (another subunit of the nuclear exosome) is
present in three complexes that are distinct from the
exosome. Many functions have been ascribed to the nuclear
exosome because of their disruption in an rrp6 mutant.
Analysis of an rrp47 mutant strain revealed that many RNA-
processing reactions indeed appear to be carried out by the
exosome. The previously reported role for the exosome in
degrading aberrant mRNAs is not affected in the rrp47
mutant, however, and may therefore reflect functions of the
non-exosomal Rrp6p-containing complexes.
Proper processing of an mRNA in the nucleus leads to its
preferential export to the cytoplasm. How does the export
machinery differentiate mature from pre-mature mRNAs?
This question was addressed by Anita Corbett (Emory Uni-
versity, Atlanta, USA). In yeast, the hnRNP protein Nab2p is
thought to function in poly(A) tail synthesis. Corbett’s group
has identified two components of the nuclear pore, Mlp1p
and Mlp2p, which interact with Nab2p. When Mlp binding
to Nab2p was inhibited, polyadenylated mRNA was retained
in the nucleus. More surprisingly, deletion of the nonessen-
tial MLP genes results in increased transport of polyadeny-
lated mRNA. This enhanced export may be due to increased
export of improperly processed mRNAs, a notion supported
by genetic interactions observed between nuclear mRNA
decay factors and the Mlp proteins. Taken together, these
data suggest that the Mlp proteins provide a quality-control
checkpoint to export properly processed mRNAs. 
Most eukaryotes preferentially degrade aberrant mRNAs
that carry a premature stop codon in a process termed non-
sense-mediated decay (NMD). Premature stop codons in
mammalian mRNAs are recognized when a stop codon is
encountered more than 55 nucleotides upstream of the junc-
tion of the last two exons. The exon-exon junction is recog-
nized by the presence of an exon-junction complex (EJC)
that is deposited by the spliceosome. David Gatfield from the
laboratory of Elisa Izaurralde (European Molecular Biology
Laboratory (EMBL) Heidelberg, Germany) reported the sur-
prising result that NMD in Drosophila more closely resem-
bles NMD in yeast, in that a poorly defined element
downstream of the premature stop codon is required instead
of the EJC. Importantly, however, flies do have homologs of
most EJC components, suggesting that the EJC may have a
role distinct from that of NMD. Chia Chan from the labora-
tory of Gideon Dreyfuss (University of Pennsylvania,
Philadelphia, USA) and Thomas Tange from Melissa
Moore’s group (Brandeis University) independently reported
the discovery of several additional components of the EJC.
One protein identified by both groups is the RNA helicase
eIF4AIII. Nahum Sonenberg’s group at McGill University,
Montreal, Canada, has previously shown that eIF4AIII is
homologous to, but functionally distinct from, the transla-
tion initiation factors eIF4AI and eIF4AII. In their published
work, Sonenberg’s group showed that eIF4AIII inhibits
translation in reticulocyte lysates, although at concentra-
tions significantly higher than are physiological. One possi-
ble explanation is that eIF4AIII represses translation on
freshly spliced mRNAs. An alternative explanation is sug-
gested by a previous report from Moore’s lab that spliced
mRNAs yield more protein per mRNA than an identical
mRNA that never contained introns. This suggests that
eIF4AIII may be important for the stimulation of translation
by the EJC. A unifying hypothesis is that the EJC functions
to signal to the translation apparatus that the message has
been properly processed.
Assembly of spliceosome and RISC complexes 
Most, if not all, reactions involved in gene expression are
carried out by large multiprotein complexes. Several presen-
tations addressed how these complexes are assembled from
their individual components. In one example, Jean Beggs
(University of Edinburgh) reported that the nuclear Lsm
complex (Lsm2p-Lsm8p) in yeast is directly involved in
U4/U6 assembly. The Lsm/U6 complex can be formed from
Lsm proteins translated in vitro and U6 snRNA transcribed
in vitro. This U6/Lsm complex was more efficient than
naked U6 snRNA in assembling with in vitro transcribed U4
snRNA. U4/U6 assembly was further enhanced by the Prp24
protein, which has previously been implicated in this
process. The U4/U6 complex has to be reassembled after
every splicing reaction. Mutant extracts lacking one of the
Lsm proteins could carry out splicing but not multiple
rounds of splicing, providing further support for a role for
Lsm proteins in U4/U6 reassembly.
The RNA interference (RNAi) pathway has become a favorite
tool for functional genomics, as it allows for inactivation of
specific gene expression in a wide range of model organisms,
but the mechanism(s) of RNAi remain largely uncharacter-
ized. A key step in RNAi appears to be the assembly of the
RISC complex, which contains small interfering RNAs
(siRNAs) of 21-23 nucleotides together with multiple pro-
teins. Erik Sontheimer (Northwestern University, Evanston,
USA) described the results of a native gel electrophoresis
analysis looking at siRNA-containing complexes. This study
identified three complexes (R1, R2 and R3), of which the R3
complex is most like the previously described RISC complex,
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be precursors that can be chased into the R3 form. Qinghua
Liu from Xiaodong Wang’s group (University of Texas
Southwestern Medical Center, Dallas, USA), Tingting Du
from the laboratory of Phillip Zamore (University of Massa-
chusetts Medical School, Worcester, USA), and Sontheimer
all reported biochemical analyses of fly mutants defective in
RISC complex assembly. Liu reported that purified Dicer
activity (the activity that generates the siRNAs) from
Drosophila cells contains the protein Dicer2 as well as the
R2D2 protein, a homolog of the Caenorhabditis elegans
RDE-4 protein that is required for RNAi. R2D2 does not
affect Dicer activity in vitro, but rather stimulates the incor-
poration of the siRNA product generated by Dicer into the
RISC complex. Du reported that the Drosophila protein
Armitage, an RNA helicase whose Arabidopsis homolog
SDE3 is required for RNAi, is also required for RISC
complex assembly on siRNAs. These studies provide further
support for the notion that the RNAi pathway is conserved
between plants and metazoans. A better understanding of
the mechanisms of RNAi should further increase its utility as
a genetic technique. 
The importance of understanding mRNA processing has
increased in the genomics era. As the number of sequenced
eukaryotic genomes gets larger, the task now is to identify
and define the messages contained within them. The human
genome is currently predicted to have roughly 30,000
protein-coding genes, but 40-60% of human genes are likely
to be subject to alternative splicing, suggesting that the
genome encodes many more products. The physiological rel-
evance of alternative splicing has been clearly demonstrated
in a variety of ways. Far less is known about how other
mRNA-processing events and alternative translation initia-
tion might impact on the proteome. The further identifica-
tion and characterization of alternative mRNA processing
events, as well as the factors controlling them, will help
clarify the capacity of the genome. For example, our under-
standing of alternative splicing will be advanced significantly
with the advent and commercial availability of microarrays
sensitive to alternative splice forms. Such tools should gen-
erate important insights into mRNA processing mechanisms
and the diseases caused when those mechanisms go awry.
We look forward to seeing advances in these and other areas
at the next ‘Eukaryotic mRNA Processing’ meeting in 2005.
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